Hepion Pharmaceuticals, Inc.
Industry
- Pharmaceuticals
- Specialty Pharmaceuticals
- Biotechnology
Other Names/Subsidiaries
- Ciclofilin Pharmaceuticals
- ContraVir Pharmaceuticals
Latest on Hepion Pharmaceuticals, Inc.
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Boehringer Ingelheim Acquires Nerio The
Bristol Myers Squibb Company and Sanofi recently joined the ranks of companies cutting costs and jobs in 2024, although not necessarily for the same reasons, as first quarter earnings season got un
Recent private placements and follow-on financings show that despite public company valuations being down across the board during the past two years, it still is possible to drum up investor support f
Late-stage development in non-alcoholic steatohepatitis (NASH) stagnated a bit in 2020 after a pair of setbacks – the US Food and Drug Administration complete response letter to Intercept for the ND